Dividend 15 Split Corp. has renewed its at-the-market (ATM) equity program, allowing it to issue shares to the public at prevailing market prices until November 7, 2028. This program replaces the previous one that ended in 2025 and enables the company to raise up to $600 million through sales on the Toronto Stock Exchange. Proceeds will be used to support the company's investment strategy in high-quality Canadian dividend-yielding stocks. The timing and volume of share sales under this program will be at the company's discretion.
Dividend 15 Split Corp.'s renewed ATM equity program is the context for this snapshot of the Financials sector on Pluang. For readers following Financials, here is Pluang's market snapshot as of Oct 08, 2026 19:12 WIB: of 118 priced Financials-sector US stocks tradable on Pluang, 12 rose and 101 fell today. Notable movers include RIOT at USD 18.08 with a 1-day change of -2.48% and 100% buy order activity, BCS at USD 22.44 with a -2.43% change and 100% buy order activity, and HSBC at USD 91.50 with a -2.36% change and 92% buy order activity.
Fieldstone Bio, a synthetic biology company, was selected for the Mining Tech Accelerator program by Founders Factory and Rio Tinto. The program supports innovative technologies that improve mineral exploration and extraction, providing Fieldstone wi...
Beam Global has signed a definitive agreement to acquire ScoutDI, a company specializing in drone technology and AI-powered inspection software. The acquisition will enable Beam to manufacture ScoutDI's drone systems in the US and Europe, targeting i...
Grabar Law Office is investigating shareholder claims against four companies—Aardvark Therapeutics, Coastal Financial Corporation, Erasca, Inc., and New Era Energy & Digital—for alleged securities violations and breaches of fiduciary duties. The clai...
Visa Canada's data reveals that the Toronto International Film Festival (TIFF) 2026 increased visitor spending by 12% compared to 2025, with international visitors spending about 40% more than Canadian cardholders. The festival attracted visitors mai...
Aclarion, Inc. has updated the enrollment criteria for its CLARITY clinical trial to better reflect real-world chronic low back pain patients and accelerate patient recruitment. The revised criteria, approved at most active sites, expand the pool of ...
